On the other hand, subgrouping resolved heterogeneity in the breast cancer subgroup, and results show a significant association between ANGPTL4 expression and worse OS (HR =  1.59, 95% CI: 1.32–1.90) (Fig 3B). The gene discussed is ANGPTL4; the disease is breast carcinoma.